Enoxaparin Dosing for Acute Coronary Syndrome with Renal Impairment
Dosing Regimen
- The American College of Cardiology recommends administering 1 mg/kg subcutaneously every 24 hours for patients with creatinine clearance less than 30 mL/min, which represents a 50% reduction in total daily dose compared to standard dosing 1, 2
- The 2025 ACC/AHA/SCAI guidelines explicitly state this dose reduction for creatinine clearance less than 30 mL/min in the acute coronary syndrome setting 1
- For patients with creatinine clearance less than 30 mL/min, give 1 mg/kg subcutaneously every 24 hours regardless of age when fibrinolytic therapy is used, and do not administer the initial IV bolus that would normally be given to younger patients 1
Rationale for Dose Reduction
- Patients with creatinine clearance less than 30 mL/min have 2.25 times higher odds of major bleeding when receiving standard doses, but dose reduction eliminates this excess bleeding risk 3
Critical Considerations
- The American Heart Association recommends never switching between enoxaparin and unfractionated heparin once therapy is initiated, as this significantly increases bleeding risk 2, 3
- Unfractionated heparin is a reasonable alternative that does not require renal dose adjustment, with dosing of 60 IU/kg IV bolus and 12 IU/kg/h infusion adjusted to aPTT 60-80 seconds 1, 2, 3
- Fondaparinux is absolutely contraindicated when creatinine clearance is less than 30 mL/min 1, 3